98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2169/internalmedicine.5456-25 | DOI Listing |
Curr Cardiol Rev
August 2025
Center of Medical Sciences, Federal University of Paraíba, João Pessoa, Brazil.
Introduction: Nonbacterial thrombotic endocarditis (NBTE) involves sterile vegetations on heart valves due to systemic hypercoagulability, often linked to malignancies. It is frequently underdiagnosed and presents significant clinical management challenges, often manifesting as thromboembolic events like ischemic stroke. We aim to report the first case of cancerassociated NBTE that showed a positive response to rivaroxaban as a maintenance anticoagulant, with 3D echocardiographic evidence of vegetation reduction, and to evaluate the performance of direct oral anticoagulants (DOACs) in treating cancer-associated NBTE through a systematic review of case reports.
View Article and Find Full Text PDFCureus
July 2025
Cardiovascular Medicine Department, Mayo Clinic, Phoenix, USA.
Non-bacterial thrombotic endocarditis (NBTE) is a rare condition characterized by sterile vegetations on cardiac valves, commonly associated with malignancy or autoimmune disorders. These vegetations pose a significant risk of embolization, leading to adverse complications such as ischemic stroke. We present a case of a 60-year-old female initially suspected of having a brain tumor, later diagnosed with multifocal strokes due to NBTE.
View Article and Find Full Text PDFCurr Neurol Neurosci Rep
July 2025
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Purpose Of This Review: This review explores the complex relationship between cancer and vascular disease. It aims to synthesize current evidence on the epidemiology, mechanisms, management, and outcomes of ischemic stroke, cerebral venous sinus thrombosis (CVST), venous thromboembolism (VTE) in brain tumor patients, and intracranial hemorrhage (ICH), while highlighting the cerebrovascular risks of systemic cancer therapies.
Recent Findings: Recent studies reveal that cancer patients are at increased risk for ischemic stroke, often from cancer-specific mechanisms such as hypercoagulability, non-bacterial thrombotic endocarditis, and tumor embolism.
Front Neurol
June 2025
Neurology Department, Medicine Universidad Autonoma de Madrid, Madrid, Spain.
Oncologic and cerebrovascular diseases are among the diseases with the highest incidence rate and are leading causes of disability and mortality. The relationship between cancer and cerebrovascular disease has been studied for decades, yet it remains a challenge. Stroke, in relation to oncologic diseases, has particularities in its diagnosis and treatment.
View Article and Find Full Text PDFCardiovasc Pathol
August 2025
Departments of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan. Electronic address:
As endovascular therapy for ischemic stroke has advanced, we are getting increasing opportunities to study cerebral thromboemboli histologically. These opportunities have not been fully exploited, but some reports suggest that thromboemboli retrieved from cancer patients with stroke are platelet-richer than those from non-cancer patients. Nonbacterial thrombotic endocarditis (NBTE) is an important cause of ischemic stroke in cancer patients.
View Article and Find Full Text PDF